Friday, May 20, 2022

[ASAP] Framework Nucleic Acid Immune Adjuvant for Transdermal Delivery Based Chemo-immunotherapy for Malignant Melanoma Treatment

TOC Graphic

Nano Letters
DOI: 10.1021/acs.nanolett.2c01332


from Nano Letters: Latest Articles (ACS Publications) https://ift.tt/ApjV3Cv
via IFTTT

No comments:

Post a Comment